SIRT6-IN-6 (compound 6d) is a potent and selective SIRT6 inhibitor with an IC 50 of 4.93 μM and a K i of ~10 μM. SIRT6-IN-6 shows selectivity against other members of the HDAC family ( SIRT1-3 and HDAC1-11 ). SIRT6-IN-6 significantly increases the level of glucose transporter GLUT-1 , thereby reducing blood glucose in a mouse model of type 2 diabetes. SIRT6-IN-6 can be used for type 2 diabetes research.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Type 2 Diabetes | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Sirtuin | Products > Signaling Pathways > GLUT
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.